-
A44509-25G
ALPHA-AMINO-GAMMA-BUTYROLACTONE HYDRO- BROMIDE 99%
Price: $1,601.57List Price: $1,779.52alpha-Amino-gamma-butyrolactone hydrobromide -
AB5398
ANTI-VANILLOID RECEPTOR LIKE PROTEIN 1 ANTIBODY PAIN CT (C15-1316-242)
Price: $1,078.09List Price: $1,197.88Specificity Vanilloid receptor like protein 1 (VRL-1). Immunohistochemical analysis of rat dorsal root ganglia and spinal cord indicates that this antibody is of high specificity. -
AB5398P
ANTI-VANILLOID RECEPTOR LIKE PROTEIN ANTIBODY PAIN CT (C15-1316-243)
Price: $1,078.09List Price: $1,197.88Specificity Vanilloid receptor like protein 1 (VRL-1). Immunohistochemical analysis of rat dorsal root ganglia and spinal cord indicates specific staining in a subpopulation of sensory neurons. -
90051-10
Arachidonoyl Glycine-10 mg
Price: $226.45List Price: $251.61Produced endogenously via oxidation of AEA, or by transacylation of arachidonoyl CoA has analgesic activities in whole animal experiments, yet is a very poor ligand for the CB1 receptor. -
90054-100
Arachidonoyl-2'-Fluoroethylamide-100 mg
Price: $1,495.27List Price: $1,661.41An analog of AEA in which the alcohol of the ethanolamide group has been replaced with a fluorine atom, which increases the binding affinity and selectivity for the CB1 receptor in vivo activity is enhanced much less than the binding affinity, -
90054-50
Arachidonoyl-2'-Fluoroethylamide-50 mg
Price: $858.75List Price: $954.16An analog of AEA in which the alcohol of the ethanolamide group has been replaced with a fluorine atom, which increases the binding affinity and selectivity for the CB1 receptor in vivo activity is enhanced much less than the binding affinity, -
13823-1
AX 048-1 mg
Price: $655.07List Price: $727.86A potent group IVA cPLA2 inhibitor (XI(50) = 0.022) reduces thermal hyperalgesia evoked by carrageenan injection of rat hind paw (ED<sub>50</sub> = 1.2 mg/kg) does not inhibit COX activity or interfere with CB1 receptor signaling. -
13823-5
AX 048-5 mg
Price: $2,155.51List Price: $2,395.01A potent group IVA cPLA2 inhibitor (XI(50) = 0.022) reduces thermal hyperalgesia evoked by carrageenan injection of rat hind paw (ED<sub>50</sub> = 1.2 mg/kg) does not inhibit COX activity or interfere with CB1 receptor signaling. -
66968-U
BIOSHELL A160 PEPTIDE CN 2.7UM 10CM X 2.1MM (C15-1307-514)
Price: $1,996.00List Price: $2,217.78BIOshell ™ 160Ã… Peptide CN columns provide an alternative selectivity to the traditional C18 bonded phases. The introduction of the cyano group enables peptides and small proteins to be separated due to a combination of hydrophobicity and -
66975-U
BIOSHELL A160 PEPTIDE CN 2.7UM 10CM X 4.6MM (C15-1307-520)
Price: $1,996.00List Price: $2,217.78BIOshell ™ 160Ã… Peptide CN columns provide an alternative selectivity to the traditional C18 bonded phases. The introduction of the cyano group enables peptides and small proteins to be separated due to a combination of hydrophobicity and -
66969-U
BIOSHELL A160 PEPTIDE CN 2.7UM 15CM X 2.1MM (C15-1307-515)
Price: $2,193.81List Price: $2,437.56BIOshell ™ 160Ã… Peptide CN columns provide an alternative selectivity to the traditional C18 bonded phases. The introduction of the cyano group enables peptides and small proteins to be separated due to a combination of hydrophobicity and -
66973-U
BIOSHELL A160 PEPTIDE CN 2.7UM 15CM X 3.0MM (C15-1307-518)
Price: $2,193.81List Price: $2,437.56BIOshell ™ 160Ã… Peptide CN columns provide an alternative selectivity to the traditional C18 bonded phases. The introduction of the cyano group enables peptides and small proteins to be separated due to a combination of hydrophobicity and